Immortal.life Signals

Which longevity trials reached a visible registry milestone?

A source-linked ledger of recently updated trial registrations, their current status and the countries shown in the registry.

Signal Trial watch

Which longevity-related trial registrations carry an official update date from the last six weeks?

265 published trial registrations carry an official registry update date in this six-week window. Current status is descriptive and does not establish results, effectiveness or safety.

265recently updated registrationsOfficial six-week update window98currently recruitingCurrent registry status69currently completedResults may or may not be posted167registrations in prior windowSame registry-update definition
Registry milestones

The registry moved.

A source-linked ledger of recently updated trial registrations, their current status and the countries shown in the registry.

Why it was publishedVerified

The edition passed its minimum source-volume and reuse-rights rules. Missing or ambiguous cohorts remain unpublished.

What it means

One observable movement, clearly bounded.

A registry update and current status do not show that an intervention worked, was safe, recruited the planned population or produced a published result.

Open the evidence

Records behind this Signal

  1. Registry updated 2026-10-05Perioperative Biomarkers and Postoperative Delirium in Older Adults Undergoing Abdominal Cancer SurgeryRecruiting
  2. Registry updated 2026-10-05Wearable Robotics to Overcome Exercise Dose Limitations in Older Adults - Study 1Not Yet Recruiting
  3. Registry updated 2026-10-05Online Interactive Meditation Training Enhances Well-being in Older AdultsCompleted
  4. Registry updated 2026-10-05Biomarkers, Abdominal Muscle, and Frailty in CKDCompleted
  5. Registry updated 2026-10-05VICIA FABA PEPTIDES AND RESISTANCE TRAINING IN THE ELDERLYEnrolling By Invitation
  6. Registry updated 2026-10-05Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) AntagonistsRecruiting
  7. Registry updated 2026-10-05Aflibercept After Ranibizumab in Exudative Age-related Macular DegenerationCompleted
  8. Registry updated 2026-10-05Rehabilitating Vision Loss in Veterans With Age-Related Macular DegenerationWithdrawn
  9. Registry updated 2026-10-05The Impact of Biological Mechanisms of Aging on Response Variability to Resistance Training in Older AdultsRecruiting
  10. Registry updated 2026-10-05Sustainable Exercise and Nutrition Programs for Managing Metabolic Disorders in Older WomenActive Not Recruiting
  11. Registry updated 2026-10-05Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialRecruiting
  12. Registry updated 2026-10-05Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple MyelomaSuspended
For journalists and researchers

Use the figure. Check the records.

Suggested citation: immortal.life Signals, “Which longevity trials reached a visible registry milestone?,” data accessed October 6, 2026.